Skip to content

13F-HR filed by Matrix Capital Management Company, LP

Matrix Capital Management Company, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 17 holding rows worth $7,362,176,099.

Accession
0001172661-23-002292
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 17 entries on the cover page, a total value of $7,362,176,099 stated on the cover page (in dollars after the unit check, H1), rows summing to $7,362,176,099 with VALUE read as dollars as filed, 13F file number 028-12595. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NVIDIA Corp67066G104COM5,414,600$1,504,013,442dollars as filed
GLOBALFOUNDRIES INCG39387108ORDINARY SHARES17,848,000$1,288,268,640dollars as filed
TRANSDIGM GROUP INC COM893641100Stock1,094,900$806,996,045dollars as filed
ALTAIR ENGINEERING INC021369103COMMON STOCK11,174,200$805,771,562dollars as filed
Applied Materials,Inc.038222105COM6,297,700$773,546,491dollars as filed
Amazon.com, Inc023135106COM7,335,828$757,717,674dollars as filed
ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHSN07059210STOK497,200$338,449,012dollars as filed
WORKDAY INC CL A98138H101Stock1,586,043$327,581,321dollars as filed
SYNOPSYS INC COM871607107Stock609,735$235,510,144dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK9,199,973$158,239,536dollars as filed
Energy Select Sector SPDR Fund81369Y506SHS1,282,000$106,188,060dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock11,572,590$102,185,970dollars as filed
PERIMETER SOLUTIONS SAL7579L106COMMON STOCK-FO7,462,500$60,297,000dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK5,362,870$49,767,434dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR38,974,185$42,481,862dollars as filed
Ventyx Biosciences Inc92332V107Common Stock89,900$3,011,650dollars as filed
ZSCALERINC98980G102STOK18,405$2,150,256dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-23-002292this filing2023-05-15acceptance time not in the bulk data set